Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Selection of a Relevant In Vitro Blood-Brain Barrier Model to Investigate Pro-Metastatic Features of Human Breast Cancer Cell Lines.

Drolez A, Vandenhaute E, Julien S, Gosselet F, Burchell J, Cecchelli R, Delannoy P, Dehouck MP, Mysiorek C.

PLoS One. 2016 Mar 9;11(3):e0151155. doi: 10.1371/journal.pone.0151155. eCollection 2016.

2.

Adapting coculture in vitro models of the blood-brain barrier for use in cancer research: maintaining an appropriate endothelial monolayer for the assessment of transendothelial migration.

Vandenhaute E, Drolez A, Sevin E, Gosselet F, Mysiorek C, Dehouck MP.

Lab Invest. 2016 May;96(5):588-98. doi: 10.1038/labinvest.2016.35. Epub 2016 Feb 22.

3.

Cancer-associated fibroblast promote transmigration through endothelial brain cells in three-dimensional in vitro models.

Choi YP, Lee JH, Gao MQ, Kim BG, Kang S, Kim SH, Cho NH.

Int J Cancer. 2014 Nov 1;135(9):2024-33. doi: 10.1002/ijc.28848. Epub 2014 Mar 28.

4.

ST6GALNAC5 Expression Decreases the Interactions between Breast Cancer Cells and the Human Blood-Brain Barrier.

Drolez A, Vandenhaute E, Delannoy CP, Dewald JH, Gosselet F, Cecchelli R, Julien S, Dehouck MP, Delannoy P, Mysiorek C.

Int J Mol Sci. 2016 Aug 11;17(8). pii: E1309. doi: 10.3390/ijms17081309.

5.

Organization of Endothelial Cells, Pericytes, and Astrocytes into a 3D Microfluidic in Vitro Model of the Blood-Brain Barrier.

Wang JD, Khafagy el-S, Khanafer K, Takayama S, ElSayed ME.

Mol Pharm. 2016 Mar 7;13(3):895-906. doi: 10.1021/acs.molpharmaceut.5b00805. Epub 2016 Jan 27.

PMID:
26751280
6.
7.

Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model.

Burek M, Salvador E, Förster CY.

J Vis Exp. 2012 Aug 29;(66):e4022. doi: 10.3791/4022.

8.

In vitro models for the blood-brain barrier.

Garberg P, Ball M, Borg N, Cecchelli R, Fenart L, Hurst RD, Lindmark T, Mabondzo A, Nilsson JE, Raub TJ, Stanimirovic D, Terasaki T, Oberg JO, Osterberg T.

Toxicol In Vitro. 2005 Apr;19(3):299-334.

PMID:
15713540
9.

Transfection of brain capillary endothelial cells in primary culture with defined blood-brain barrier properties.

Burkhart A, Thomsen LB, Thomsen MS, Lichota J, Fazakas C, Krizbai I, Moos T.

Fluids Barriers CNS. 2015 Aug 7;12:19. doi: 10.1186/s12987-015-0015-9.

10.

Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line.

Boveri M, Berezowski V, Price A, Slupek S, Lenfant AM, Benaud C, Hartung T, Cecchelli R, Prieto P, Dehouck MP.

Glia. 2005 Aug 15;51(3):187-98.

PMID:
15800928
11.

Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models.

Hellinger E, Veszelka S, Tóth AE, Walter F, Kittel A, Bakk ML, Tihanyi K, Háda V, Nakagawa S, Duy TD, Niwa M, Deli MA, Vastag M.

Eur J Pharm Biopharm. 2012 Oct;82(2):340-51. doi: 10.1016/j.ejpb.2012.07.020. Epub 2012 Aug 11.

PMID:
22906709
12.

Glial-cell-mediated re-induction of the blood-brain barrier phenotype in brain capillary endothelial cells: a differential gel electrophoresis study.

Deracinois B, Pottiez G, Chafey P, Teerlink T, Camoin L, Davids M, Broussard C, Couraud PO, Dehouck MP, Cecchelli R, Karamanos Y, Flahaut C.

Proteomics. 2013 Apr;13(7):1185-99. doi: 10.1002/pmic.201200166.

PMID:
23436736
13.

A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells.

Cecchelli R, Aday S, Sevin E, Almeida C, Culot M, Dehouck L, Coisne C, Engelhardt B, Dehouck MP, Ferreira L.

PLoS One. 2014 Jun 17;9(6):e99733. doi: 10.1371/journal.pone.0099733. eCollection 2014.

14.

Pericytes are required for blood-brain barrier integrity during embryogenesis.

Daneman R, Zhou L, Kebede AA, Barres BA.

Nature. 2010 Nov 25;468(7323):562-6. doi: 10.1038/nature09513. Epub 2010 Oct 13.

15.

Human brain endothelial cell-derived COX-2 facilitates extravasation of breast cancer cells across the blood-brain barrier.

Lee KY, Kim YJ, Yoo H, Lee SH, Park JB, Kim HJ.

Anticancer Res. 2011 Dec;31(12):4307-13.

PMID:
22199296
16.

The proinflammatory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions.

Rodriguez PL, Jiang S, Fu Y, Avraham S, Avraham HK.

Int J Cancer. 2014 Mar 1;134(5):1034-44. doi: 10.1002/ijc.28433. Epub 2013 Sep 3.

17.

Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-α, releasing matrix metalloproteinase-9 and migrating in vitro.

Takata F, Dohgu S, Matsumoto J, Takahashi H, Machida T, Wakigawa T, Harada E, Miyaji H, Koga M, Nishioku T, Yamauchi A, Kataoka Y.

J Neuroinflammation. 2011 Aug 26;8:106. doi: 10.1186/1742-2094-8-106.

18.

Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.

Park EJ, Zhang YZ, Vykhodtseva N, McDannold N.

J Control Release. 2012 Nov 10;163(3):277-84. doi: 10.1016/j.jconrel.2012.09.007. Epub 2012 Sep 18.

19.

Foxf2 Is Required for Brain Pericyte Differentiation and Development and Maintenance of the Blood-Brain Barrier.

Reyahi A, Nik AM, Ghiami M, Gritli-Linde A, Pontén F, Johansson BR, Carlsson P.

Dev Cell. 2015 Jul 6;34(1):19-32. doi: 10.1016/j.devcel.2015.05.008. Epub 2015 Jun 25.

20.

In vitro models of the blood-brain barrier.

Czupalla CJ, Liebner S, Devraj K.

Methods Mol Biol. 2014;1135:415-37. doi: 10.1007/978-1-4939-0320-7_34.

PMID:
24510883

Supplemental Content

Support Center